dihexa oral | | 1401708-83-5 Dihexa - PRAMAH / THE

The original rationale for studying the gastric pentadecapeptide was cytoprotection of gastrointestinal mucosa

Commonly reported side effects remain mild and often transient

Gallbladder: Increased risk of gallstones/cholelithiasis is documented with GLP-1 weight-loss dosing and is part of the class picture

The molecular weight distribution of these collagen peptides is determined by high performance size exclusion chromatography (HPSEC) using an Agilent HPLC, 1260 Infinity series (G1316A, G1329B, G1311C, G1315D) with a TSKgel SWXL precolumn und a G2000SWXL column (Tosoh Bioscience)

Available exclusively for licensed research and laboratory use

Dette samarbejde hjlper ogs med at justere tilgangen efter lokale forhold og kultur, hvilket ger chancerne for vedvarende effekt